Global AI-based Breast Cancer Detection Solution Market Growth (Status and Outlook) 2025-2031

The global AI-based Breast Cancer Detection Solution market size is predicted to grow from US$ 680 million in 2025 to US$ 1194 million in 2031; it is expected to grow at a CAGR of 9.9% from 2025 to 2031.

According to the latest global cancer burden data for 2020 released by the World Health Organization's International Agency for Research on Cancer (IARC), the number of new breast cancer cases worldwide reached 2.26 million, exceeding the 2.2 million cases of lung cancer. Breast cancer replaced lung cancer and became the world's largest cancer.

In the absence of a good strategy for early prevention, early screening, early detection, and early treatment are particularly important. In the early screening stage, artificial intelligence participates in breast imaging interpretation, covering a large number of people and making screening more accurate and efficient. Breast cancer screening based on AI technology is a method of analyzing and interpreting breast images using artificial intelligence algorithms. It can quickly process a large amount of image data and identify potential lesion characteristics, thereby achieving high-precision early diagnosis; this screening technology significantly improves the efficiency and quality of diagnosis with its high efficiency and accuracy, and provides doctors with reliable auxiliary decision support; the application of this technology gives AI technology important significance in the medical field and promotes the development of medical diagnosis towards intelligence and precision.

United States market for AI-based Breast Cancer Detection Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for AI-based Breast Cancer Detection Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for AI-based Breast Cancer Detection Solution is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key AI-based Breast Cancer Detection Solution players cover Therapixel, NIRAMAI Health Analytix, ScreenPoint Medical, Kheiron, Volpara Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “AI-based Breast Cancer Detection Solution Industry Forecast” looks at past sales and reviews total world AI-based Breast Cancer Detection Solution sales in 2024, providing a comprehensive analysis by region and market sector of projected AI-based Breast Cancer Detection Solution sales for 2025 through 2031. With AI-based Breast Cancer Detection Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-based Breast Cancer Detection Solution industry.

This Insight Report provides a comprehensive analysis of the global AI-based Breast Cancer Detection Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI-based Breast Cancer Detection Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI-based Breast Cancer Detection Solution market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-based Breast Cancer Detection Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-based Breast Cancer Detection Solution.

This report presents a comprehensive overview, market shares, and growth opportunities of AI-based Breast Cancer Detection Solution market by product type, application, key players and key regions and countries.

Segmentation by Type:
AI Breast Ultrasound System (Robot)
AI-based Breast Cancer Detection Software

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Therapixel
NIRAMAI Health Analytix
ScreenPoint Medical
Kheiron
Volpara Health
Hologic
Philips
Intel
iCAD
Shanghai Lianying Intelligent Medical Technology
Guangzhou Shangy Information Technology
Shenzhen Aisono
Shantou Institute of Ultrasonic Instrument

Please note: The report will take approximately 2 business days to prepare and deliver.